Do Public Hearing Participants Influence Outcomes of FDA Advisory Committee Meetings?

Posted 30 September 2015 By Natalie Vargas, MPH, MBA

placeholder+image This article discusses the importance of the open public hearing portion of an FDA Advisory Committee meeting.

Share this article:

Categories: Biologics and biotechnology, Drugs, Medical Devices, Government affairs, Submission and registration, Features, US, FDA

Tags: Advisory Committee Meetings, Open Public Hearing,

Regulatory Exchange: Latest Updates From the Community